Global Interventional Pulmonology Market Size Study & Forecast, by Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial The

Global Interventional Pulmonology Market Size Study & Forecast, by Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), by Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), by End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others), and Regional Analysis, 2023-2030

Global Interventional Pulmonology Market is valued at approximately USD 3.95 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2023-2030. Interventional pulmonology is a medical specialty that focuses on the detection and treatment of different illnesses and ailments which impact the respiratory system, particularly the lungs, and airways. Advanced endoscopic methods and minimally invasive treatments are used in this new and rapidly evolving field to offer diagnostic and therapeutic approaches for patients with lung and airway problems. The rising inclination towards the minimally invasive nature of procedures, growing emphasis on early diagnosis and screening, rising geriatric population, and favorable reimbursement policies are the major factors that are fueling the market demand across the globe.

The rising prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and various pulmonary infections has led to a growing demand for interventional pulmonology procedures. According to the World Health Organization, in 2020, it was estimated that nearly 2.21 million new cases of trachea, bronchus, and lung cancer were recorded globally, which is projected to rise and is likely to reach 3.63 million new cases by 2040. As these conditions become more prevalent, the need for minimally invasive diagnostic and therapeutic interventions provided by interventional pulmonology increases. Thus, these aforementioned factors are propelling the growth of the Interventional Pulmonology Market during the estimated period. Moreover, the increasing technological advancements in endoscopic techniques, as well as the ongoing research and development activities present various lucrative opportunities over the forecast years. However, the high cost of procedures and equipment and the dearth of specialized training and expertise are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Interventional Pulmonology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing technological developments related to endoscopic procedures, and a shift towards minimally invasive surgery in developed nations such as the U.S. Additionally, the escalation of air pollution and the prevalence of lung disorders brought on by heavy smoking are significant market development factors. Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing aging population, rising healthcare spending, and improvements in lung disease diagnosis and treatment are significantly propelling the market demand across the region.

Major market players included in this report are:
Argon Medical Systems LLP
Body Vision Medical Ltd.
Boston Scientific Corporation
C. R. Bard, Inc. (Becton, Dickinson and Company)
CONMED Corporation
ENDO-FLEX GmbH
Fujifilm Corporation
KARL STORZ SE & Co. KG
Medtronic
Olympus Corporation

Recent Developments in the Market:
In April 2021, Olympus Corporation unveiled the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a range of five premium endoscopes for use in innovative diagnostic and therapeutic procedures, have been added to Olympus Corporation's U.S. bronchoscopy portfolio.

Global Interventional Pulmonology Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Indication, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Bronchoscopes
Electromagnetic Navigation Bronchoscopy System
Pleuroscopes
Respiratory Endotherapy Devices
Airway Stents
Pleural Catheters
Endobronchial Valves
Bronchial Thermoplasty Systems

By Indication:
Asthma
COPD
Lung Cancer
Tracheal and Bronchial Stenosis
Others

By End-user:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Specialty Clinics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa


Companies Mentioned
Argon Medical Systems LLP
Body Vision Medical Ltd.
Boston Scientific Corporation
C. R. Bard, Inc. (Becton, Dickinson and Company)
CONMED Corporation
ENDO-FLEX GmbH
Fujifilm Corporation
KARL STORZ SE & Co. KG
Medtronic
Olympus Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.